🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Immunogenicity and Safety of a Live Attenuated Varicella Vaccine in Adolesc...
Status
Completed
Location
Huaiyin District Center for Disease Control and prevention
Start Date
2019-07-21
Trial ID
NCT06592456
Treatments Being Tested
The purpose of this study is to assess immune response and safety of variou...
Status
Completed
Location
GSK Investigational Site
Start Date
2022-02-03
Trial ID
NCT05084508
Treatments Being Tested
The purpose of this study is to assess how well-tolerated GSK's investigati...
Status
Recruiting
Location
GSK Investigational Site
Start Date
2024-11-26
Trial ID
NCT06693895
The purpose of this study is to evaluate the immune response and safety of ...
Status
Recruiting
Location
GSK Investigational Site
Start Date
2025-05-15
Trial ID
NCT06806137
The purpose of this study is to assess the consistency of immune response t...
Status
Recruiting
Location
GSK Investigational Site
Start Date
2025-01-10
Trial ID
NCT06740630
This is a multicenter retrospective cohort study to evaluate the long-term ...
Status
Recruiting
Location
Jiangsu Provincial Center for Diseases Control and Prevention (Jiangsu Provincial Academy of Preventive Medicine)
Start Date
2026-03-06
Trial ID
NCT07585370
This study aims to assess the immune response and safety of GSK's candidate...
Status
Recruiting
Location
GSK Investigational Site
Start Date
2025-04-17
Trial ID
NCT06855160
Immunogenicity and Safety of a Live Attenuated Varicella Vaccine in Childre...
Status
Completed
Location
Huaiyin District Center for Disease Control and Prevention
Start Date
2019-02-10
Trial ID
NCT06614816
Treatments Being Tested
The main purpose of this study is to assess immune response and safety of v...
Status
Completed
Location
GSK Investigational Site
Start Date
2022-12-14
Trial ID
NCT05630846